Gao et al. observed significantly elevated serum levels of the inflammation marker CRP and the inflammatory mediator TNFSF13 in patients with PDAC-DM, which notably decreased after lesion resection.355 This finding suggests that acute inflammation could be a potential target for diagnosing and treating PDAC-DM. The gene discussed is TNFSF13; the disease is diabetes mellitus.